Azitra, Inc. AZTR
0.63 USD 0.00 (+0.00%)
Regular-session close
0.63 0.00 -0.11%
Pre-market · Nov 17, 9:16 AM ET
Day range unavailable
0.52 52-week range 3.91
- YTD
- -76.34%
- 1 year
- -82.77%
Benzinga news
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Dare Bioscience (NASDAQ:DARE) shares rose 9.5% to $0.64 during Monday's after-market session. The company's market cap stands at $12.9 million. As per the press release, Q3 earnings came out…benzinga.com Anitra Q3 EPS $(0.29) Misses $(0.23) Estimate Anitra (AMEX:AZTR) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.23) by 31.82 percent. This is a 56.72 percent increase over losses of $(0.67) per…
benzinga.com Azitra To Present Pipeline Updates Including Results For ATR-COSF Program, Designed To Deliver Filaggrin Domains Into Human Skin To Reduce Appearance Of Fine Lines And Wrinkles, At BIO-Europe Initial results from first-in-human study with ATR-COSF anticipated by year-endBRANFORD, Conn., Nov. 10, 2026 /PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE:AZTR), a clinical-stage
benzinga.com Azitra Expands Eligibility For Ongoing Phase 1/2 Clinical Trial Of ATR04-484 To Include Individuals With Rash Associated With KRAS And MEK Inhibitors Expanded eligibility significantly broadens potential treatment opportunities for ATR-04 beyond EGFR inhibitor-associated skin rashAdditional protocol modifications expected to facilitate patient…
benzinga.com Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket Celestica jumps 16.4% after beating Q3 FY26 estimates and raising guidance; 22nd Century leads premarket gainers at 69.8%.benzinga.com Azitra Suspends ATM Offering Program For The Foreseeable Future; From September 28, 2026 - October 26, 2026, The Company Sold An Aggregate Of 1,000 Shares Of Common Stock Under The ATM Program For Aggregate Gross Proceeds Of ~$126 ATM Program Effective October 26, 2026, the Company has decided not to utilize its at-the-market offering program (the "ATM Program") under the sales agreement, dated September 28, 2026, between the…
benzinga.com Azitra To Present Progress For Its Cosmetic ATR-COSF Program Targeting Fine Lines And Wrinkles At Bio-europe, November 10; First-In-Human Study With ATR-COSF Initial Results Anticipated By End Of 2026 ATR-COSF uses a supernatant based formulation containing an active recombinant human domain of the protein, filaggrin.Ex vivo data in two models of recent cosmetic surgery explants showed visible…
